Indeed, CD surface markers presented in Table 1 either require a broader validation in osteosarcoma tissue cohorts or they have been detected also in other CSC types; for example, CD44/CD271 in melanoma [81] and CD117 in ovarian cancer [82]. Here, CTLA4 is linked to osteosarcoma.